Please assess the completion status of the following clinical trial:

Trial Title: A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCC

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \>18 years~* Karnofsky index \>70%~* Child-Turgotte-Pugh A or B liver score.~* An initial diagnosis of primary HCC or recurrence.~* A technically unresectable lesion or medically contraindicated surgery or a case in which surgery was declined.~* HCC (single nodule ≤ 5 cm or max 3 nodules ≤ 3 cm) diagnosed by histology or non-invasive EASL criteria~* Baseline CT or MRI and bone scan without evidence of radiologically definable major vascular invasion or extrahepatic disease~* Hb \>10.5.0 g/%, WBC \>3.000 cells/mm3, platelets \>50.000 cells/mm3, bilirubin \<2 mg/dl, aspartate and alanine aminotransferase levels \<5 times upper normal limit, and prothrombin time-international normalized ratio ≤ 2;~* Serum creatinine \<1.7 mg/dl~* Previously incomplete TAE or TACE with radiologically defined residual disease.~* Informed consent~Exclusion Criteria:~* Extrahepatic disease and refractory ascites.~* Previous abdominal radiation therapy (RT)~* Hemorrhage/bleeding event = Grade 3 within 4 weeks of enrollment in the study.~* Pregnant or breastfeeding patients.~* Patients with uncontrolled infections or HIV seropositive patients.~* Mental conditions rendering the patient incapable to understand the nature, scope, and consequences of the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 95 Years
- Healthy Volunteers: t

Study Arms:
- Stereotactic body radiation therapy (Type: EXPERIMENTAL): HCC after incomplete TAE or TACE treated by SBRT
- TACE/TAE (Type: ACTIVE_COMPARATOR): HCC after incomplete TAE or TACE treated by a new cycle of TAE or TACE

Based on this trial design, predict the completion outcome and termination type (if applicable).